Abstract
Tricuspid valve pathology has increasingly become the focus of attention in recent years. Both primary and secondary disease processes involve the tricuspid valve. Depending on the underlying disease process the predominant hemodynamic lesion can be either tricuspid valve stenosis or regurgitation. Whereas tricuspid stenosis is uncommon, tricuspid regurgitation is frequently encountered and is most often secondary in nature. Patients with tricuspid valve disease are usually in an advanced stage of multivalvular heart disease and constitute a high-risk group. Recent improved understanding of the pathophysiology of tricuspid valve disease coupled with substantial advances in assessment and management have improved the outlook for patients with tricuspid valve pathology. This chapter provides an overview of tricuspid valve pathology focusing on pathophysiology, diagnosis, management and emerging transcatheter therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shah PM, Raney AA. Tricuspid valve disease. Curr Probl Cardiol. 2008;33:47–84.
Bruce CJ, Connolly HM. Right-sided valve disease deserves a little more respect. Circulation. 2009;119:2726–34.
Guenther T, Norbauer C, Mazzitelli D, Busch RB, Tassani-Prell P, Lange R. Tricuspid valve surgery: a thirty-year assessment of early and late outcome. J Cardiothorac Surg. 2008;34:402–9.
Singh SK, Tang GHL, Maganti MD, Armstrong S, Williams WG, David TE, et al. Midterm outcomes of tricuspid valve repair versus replacement for organic tricuspid disease. Ann Thorac Surg. 2006;82:1735–41.
McCarthy PM, Bhudia SK, Rajeswaran J, Hoercher KJ, Lytle BW, Cosgrove DM, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004;127:674–85.
Shah PM. Tricuspid and pulmonary valve disease evaluation and management. Rev Esp Cardiol. 2010;63:1349–65.
Tei C, Pilgrim JP, Shah PM, Ormiston JA, Wong M. The tricuspid valve annulus: study of size and motion in normal subjects and in patients with tricuspid regurgitation. Circulation. 1982;6:665–71.
Joudinaud TM, Flecher EM, Duran CM. Functional terminology for the tricuspid valve. J Heart Valve Dis. 2006;15:382–8.
Waller BF, Moriarty AT, Eble JN, Davey DM, Hawley DA, Pless JE. Etiology of pure tricuspid regurgitation based on annular circumference and leaflet area: analysis of 45 necropsy patients with clinical and morphologic evidence of pure tricuspid regurgitation. J Am Coll Cardiol. 1986;7:1063–74.
Waller BF, Howard J, Fess S. Pathology of tricuspid valve stenosis and pure tricuspid regurgitation part III. Clin Cardiol. 1995;18:225–30.
Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease. J Am Coll Cardiol. 2009;53:401–8.
Adler DS. Non-functional tricuspid valve disease. Ann Cardiothorac Surg. 2017;6:204–13.
Wooley CF, Fontana ME, Kilman JW, Ryan JM. Tricuspid stenosis: atrial systolic murmur, tricuspid opening snap, and right atrial pressure pulse. Am J Med. 1985;78:375–84.
Tei C, Shah PM, Tanaka H. Phonographic-echographic documentation of systolic honk in tricuspid prolapse. Am Heart J. 1982;103:294–5.
Rivera JM, Vandervoort PM, Vazquez de Prada JA, Mele D, Karson TH, Morehead A. Which physical factors determine tricuspid regurgitation jet area in the clinical setting? Am J Cardiol. 1993;72:1305–9.
Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. A report from the American Society of Echocardiography’s nomenclature and standards committee and the task force on valvular regurgitation. J Am Soc Echocardiogr. 2003;16:777–802.
Tei C, Shah PM, Cherian G, Trim PA, Wong M, Ormiston JA. Echocardiographic evaluation of normal and prolapsed tricuspid valve leaflets. Am J Cardiol. 1983;52:796–800.
Fuster V, O’Rourke RA, Poole-Wilson P. Tricuspid valve, pulmonary valve and multiple valve disease. Hurst’s The Heart. 2009;13:1745–56.
Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation or dilatation: which should be criteria for surgical repair? Ann Thorac Surg. 2005;79:127–32.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129:2440–92.
Bernal JM, Pontón A, Diaz B, Llorca J, García I, Sarralde A, Diago C, Revuelta JM. Surgery for rheumatic tricuspid valve disease: a 30-year experience. J Thorac Cardiovasc Surg. 2008;136:476–81.
Raja SG, Dreyfus GD. Surgery for functional tricuspid regurgitation: current techniques, outcomes and emerging concepts. Expert Rev Cardiovasc Ther. 2009;7:73–84.
De Vega NG. Selective, adjustable and permanent annuloplasty. An original technic for the treatment of tricuspid insufficiency. Rev Esp Cardiol. 1972;25:555–6. [Spanish].
Hata H, Fujita T, Shimahara Y, Sato S, Kobayashi J. Early and mid-term outcomes of aggressive tricuspid annuloplasty with the MC3 ring. J Heart Valve Dis. 2014;23:601–8.
Alfieri O, De Bonis M, Lapenna E, Agricola E, Quarti A, Maisano F. The “clover technique” as a novel approach for correction of post-traumatic tricuspid regurgitation. J Thorac Cardiovasc Surg. 2003;126:75–9.
Lai YQ, Meng X, Bai T, Zhang C, Luo Y, Zhang ZG. Edge-to-edge tricuspid valve repair: an adjuvant technique for residual tricuspid regurgitation. Ann Thorac Surg. 2006;81:2179–82.
Kay JH, Maselli-Campagna G, Tsuji KK. Surgical treatment of tricuspid insufficiency. Ann Surg. 1965;162:53–8.
Dreyfus GD, Raja SG, John Chan KM. Tricuspid leaflet augmentation to address severe tethering in functional tricuspid regurgitation. Eur J Cardiothorac Surg. 2008;34:908–10.
Tanaka M, Ohata T, Fukuda S, Kigawa I, Yamashita Y, Wanibuchi Y. Tricuspid valve supra-annular implantation in adult patients with Ebstein’s anomaly. Ann Thorac Surg. 2001;71:582–6.
Ratnatunga CP, Edwards MB, Dore CJ, Taylor KM. Tricuspid valve replacement: UK heart valve registry mid-term results comparing mechanical and biological prostheses. Ann Thorac Surg. 1998;66:1940–7.
Rizzoli G, Vendramin I, Nesseris G, Bottio T, Guglielmi C, Schiavon L. Biological or mechanical prostheses in tricuspid position? A meta-analysis of intra-institutional results. Ann Thorac Surg. 2004;77:1607–14.
Al-Najashi KS, Balint OH, Oechslin E, Williams WG, Silversides CK. Mid-term outcomes in adults with Ebstein anomaly and cavopulmonary shunts. Ann Thorac Surg. 2009;88:131–6.
Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, et al. Functional status after operation for Ebstein anomaly. J Am Coll Cardiol. 2008;52(6):460–6.
Moller JE, Pellikka PA, Bernheim AM, Schaff HV, Rubin J, Connolly HM. Prognosis of carcinoid heart disease analysis of 200 cases over two decades. Circulation. 2005;112:3320–7.
Raja SG, Bhattacharyya S, Davar J, Dreyfus GD. Surgery for carcinoid heart disease: current outcomes, concerns and controversies. Futur Cardiol. 2010;6:647–55.
Yee ES, Khonsari S. Right-sided infective endocarditis: valvuloplasty, valvectomy or replacement. J Cardiovasc Surg. 1989;30:744–8.
Konstantinov IE. Total resection and complete reconstruction of the tricuspid valve in acute infective endocarditis. J Thorac Cardiovasc Surg. 2008;136(2):531.
Veerbhadran SP, Pillai VV, Sasidharan B, Karunakaran J. Surgery for congenital tricuspid valve cleft: tricuspid valve repair with neochordae and annuloplasty. J Heart Valve Dis. 2015;24:525–7.
Uehara K, Minakata K, Watanabe K, Sakaguchi H, Yamazaki K, Ikeda T, et al. Tricuspid valve repair for severe tricuspid regurgitation due to pacemaker leads. Asian Cardiovasc Thorac Ann. 2016;24:541–5.
Bouleti C, Juliard JM, Himbert D, Iung B, Brochet E, Urena M, et al. Tricuspid valve and percutaneous approach: no longer the forgotten valve! Arch Cardiovasc Dis. 2016;109:55–66.
Schofer J, Bijuklic K, Tiburtius C, Hansen L, Groothuis A, Hahn RT. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol. 2015;65:1190–5.
Latib A, Agricola E, Pozzoli A, Denti P, Taramasso M, Spagnolo P, et al. First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation. JACC Cardiovasc Interv. 2015;8:e211–4.
Ruiz CE, Kliger C, Perk G, Maisano F, Cabalka AK, Landzberg M, et al. Transcatheter therapies for the treatment of valvular and paravalvular regurgitation in acquired and congenital valvular heart disease. J Am Coll Cardiol. 2015;66:169–83.
Rogers T, Ratnayaka K, Sonmez M, Franson DN, Schenke WH, Mazal JR, Kocaturk O, Chen MY, Faranesh AZ, Lederman RJ. Transatrial intrapericardial tricuspid annuloplasty. JACC Cardiovasc Interv. 2015;8:483–91.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Raja, S.G. (2018). Tricuspid Valve Pathology. In: Dumitrescu, S., Ţintoiu, I., Underwood, M. (eds) Right Heart Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-73764-5_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-73764-5_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73763-8
Online ISBN: 978-3-319-73764-5
eBook Packages: MedicineMedicine (R0)